| Literature DB >> 29178882 |
Kamelia M Osman1, Khalid S Al-Maary2, Aymen S Mubarak2, Turki M Dawoud2, Ihab M I Moussa2, Mai D S Ibrahim3, Ashgan M Hessain4, Ahmed Orabi5, Nehal M Fawzy6.
Abstract
BACKGROUND: The present investigation was an endeavor into the elucidation of the disease-causing pathogen of streptococcosis in Nile tilapia (Oreochromis niloticus) in Egypt affecting adult fish cultured and wild fish in the Nile river. Fish were obtained from commercial fishermen, collected as part of their routine fishing activities. The researchers observed the routine fishing process and selected fish for use in the study, at the point of purchase from the fisherman.Entities:
Keywords: Antibiotic resistance; L. Garvieae; L. Mesenteroides cremoris; Lancefield C; S. Dysgalactiae; Streptococcus species; Tilapia (Oreochromis spp.)
Mesh:
Substances:
Year: 2017 PMID: 29178882 PMCID: PMC5702248 DOI: 10.1186/s12917-017-1289-8
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Fig. 1a Body shape of Tilapia fish laterally compressed to oval. Lateral line interrupted with cycloid scales. Caudal fin has distinct vertical stripes and strong body vertical bands. Healthy transparently clear and spherical eye lenses. Normal glistening skin with no pathological lesions observed. b Tilapia fish showing externally eye redness, hemorrhage and ulcers on different parts of the body, hemorrhagic dorsal and tail fins, extensively detached scales and distended abdomen with signs of bleeding beneath the skin appearing as small dots the size of a pinprick or as a patch. c Shows normal appearance of Tilapia fish with normal liver, kidney, gall bladder and intestines with bright red gills. d Tilapia fish postmortum internal findings revealed tipical signs of septicemia in which severely congested gill, kidney, spleen, intestine and heart, dark gall bladder, in addition to hemorrhagic ascites, friable pale liver, muscle redness, and parts of the intestine were devoid of food
Oligonucleotide primers sequences and size of the PCR-targeted products
| Microorganism | Target Gene | Bp fragment | Primer sequence (5′ - 3′) | Annealing Temp (°C) | References |
|---|---|---|---|---|---|
|
| 16S rRNA | 112 bp | F- TAC TGA CAA ACC ATT CAT GAT G | 59 ( | [ |
| R- AAC TTC GTC ACC AAC GCG AAC | |||||
|
|
| 941 bp | F- ATC AAG TAC AGT TAG TCT | 55 | [ |
| R- ACG ATT CAA AGC TAA CTG | |||||
|
| 16S rRNA | 1100 bp | F- CAT AAC AAT GAG AAT CGC | 58 | [ |
| R- GCA CCC TCG CGG GTTG | |||||
|
| 16S rRNA | 1500 bp | F- AGA GTT TGA TCC TGG CTC AG | 52 | [ |
| R- ACG GCT ACC TTG TTA CGA CTT | |||||
|
| 16S rRNA gene | 540 bp | F- GTG CTT GCA CTT CTG ACG TTA GC | 55 | [ |
| R- TGA GCC GTG GGC TTT CAC AT | |||||
|
| MIL ( | 275 bp | F- TGC TGC AAC GGT AGC TAA TGG | 58 | [ |
| R- GAA AGG TTT CTG CTG TCC CTG | |||||
| 16srRNA | 105 bp | F- GCG TAG GTA ACC TGC CTA TTA GA | 58 | ||
| R- CGC AGG TCC ATC TAC TAGC |
Differential diagnosis between different bacterial species using growth conditions
| Isolate | Growth at | Growth on 6.5% NaCl BHI agar | Growth at 40% Bile Salt BHI agar | |||
|---|---|---|---|---|---|---|
| 10ͦ C | 45ͦ C | After | After | After | After 7 days | |
|
| After 48 h (very faint) but good after 72 h | + | No growth | Very weak growth | Weak growth | No growth |
|
| after 48 h | + | Very weak growth | Good growth | Very good growth | No growth |
|
| after 48 h (very faint) but good after 72 h | + | No growth | Very weak growth | Very good growth | No growth |
|
| After 48 h | + | very weak growth | Very weak growth | Very good growth | No growth |
|
| After 48 h (very faint) but good after 72 h | _ | No growth | No growth | No growth | No growth |
|
| No growth | + | No growth | No growth | No growth | No growth |
|
| No growth | No growth | No growth | No growth | No growth | No growth |
Prevalence and Types of Enterococcus, Lactococcus and Streptococcus species isolated from diseased fish organs using 16 s rRNA
| Matrix | Total No. | Species | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| Total | |||||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||
| Liver | 80 | 3 | 3.8 | 2 | 2.5 | 1 | 1.3 | 1 | 1.3 | 1 | 1.3 | 1 | 1.3 | 0 | 0 | 0 | 0 | 8 | 10.0 |
| Kidney | 80 | 1 | 1.3 | 0 | 0 | 1 | 1.3 | 1 | 1.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3.8 |
| Brain | 80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.3 | 0 | 0 | 1 | 1.3 |
| Spleen | 80 | 1 | 1.3 | 1 | 1.3 | 0 | 0 | 1 | 1.3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.3 | 4 | 5 |
| Ascitic fluid | 3 | 1 | 33.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 33.3 |
| Total | 323 | 6 | 1.9 | 3 | 0.9 | 2 | 0.6 | 2 | 0.9 | 1 | 0.3 | 1 | 0.3 | 1 | 0.3 | 1 | 0.3 | 17 | 5.3 |
n, number of isolates
Fig. 2Percentage resistance of the seven species of streptococci isolated from Nile tilapia (Oreochromis niloticus) to the 18 antibiotics tested
Statistical analysis between the percentage of antimicrobial resistance (y- range) and actiual concentration (x- axis) of antibiotics for the isolated seven strains
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
|
| 1 | |||||||
|
| 0.534252 | 1 | ||||||
|
| 0.434469 | 0.696294 | 1 | |||||
|
| 0.458603 | 0.7774 | 0.693549 | 1 | ||||
|
| 0.455604 | 0.783461 | 0.692309 | 0.999059 | 1 | |||
|
| 0.593849 | 0.767848 | 0.650752 | 0.953986 | 0.950886 | 1 | ||
|
| 0.555896 | 0.785501 | 0.873946 | 0.824254 | 0.823841 | 0.784558 | 1 | |
Antibiotic resistance combinations profile of the 17 Streptococcus species isolated from Nile tilapia
| Antibiotic resistance combination profile | number of isolates/17 | % of isolates | number of antibiotics | Number of classes |
|---|---|---|---|---|
| P, Am | 1 | 5.9 | 2 | 1 |
| P, Am,VA | 1 | 5.9 | 3 | 2 |
| P, Am,VA, C | 2 | 43 | 4 | 3 |
| P, Am,VA, C, RD | 1 | 5.9 | 5 | 4 |
| P, Am,VA, C, RD, OFX | 1 | 1.9 | 6 | 5 |
| P, Am,VA, C, RD, OFX, DA | 1 | 5.9 | 7 | 6 |
| P, Am,VA, C, RD, OFX, DA, E | 3 | 17.6 | 8 | 7 |
| P, Am,VA, C, RD, OFX, DA, E, TE | 7 | 41.2 | 9 | 8 |
P penicillin, Am ampicillin, Va vancomycin, C chloramphenicol, RD rifampicin, OFX ofloxacin, DA clindamycin, E erythromycin, TE tetracycline